An Expeditious Neutralization Assay for Porcine Reproductive and Respiratory Syndrome Virus Based on a Recombinant Virus Expressing Green Fluorescent Protein

Juan Wang,Jiecong Yan,Shuaiyong Wang,Ronglin Chen,Yanru Xing,Qingyan Liu,Shuolei Gao,Yuxiang Zhu,Jiannan Li,Yanjun Zhou,Tongling Shan,Wu Tong,Hao Zheng,Ning Kong,Yifeng Jiang,Changlong Liu,Guangzhi Tong,Hai Yu

DOI: https://doi.org/10.3390/cimb46020066

2024-01-23

Current Issues in Molecular Biology

Abstract:Due to the extensive genetic and antigenic variation in Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), as well as its rapid mutability and evolution, PRRS prevention and control can be challenging. An expeditious and sensitive neutralization assay for PRRSV is presented to monitor neutralizing antibodies (NAbs) in serum during vaccine research. Here, a PRRSV expressing eGFP was successfully rescued with reverse genetics based on the infectious clone HuN4-F112-eGFP which we constructed. The fluorescent protein expressions of the reporter viruses remained stable for at least five passages. Based on this reporter virus, the neutralization assay can be easily used to evaluate the level of NAbs by counting cells with green fluorescence. Compared with the classical CPE assay, the newly developed assay increases sensitivity by one- to four-fold at the early antibody response stage, thus saving 2 days of assay waiting time. By using this assay to unveil the dynamics of neutralizing antibodies against PRRSV, priming immunity through either a single virulent challenge or only vaccination could produce limited NAbs, but re-infection with PRRSV would induce a faster and stronger NAb response. Overall, the novel HuN4-F112-eGFP-based neutralization assay holds the potential to provide a highly efficient platform for evaluating the next generation of PRRS vaccines.

biochemistry & molecular biology

What problem does this paper attempt to address?

The paper mainly addresses the following issues:

1. **Challenges in the development of vaccines for Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)**: Due to the extensive genetic variability and antigenic diversity of PRRSV, and the virus's ability to rapidly mutate and evolve, preventing and controlling PRRS is highly challenging. Although various PRRSV vaccines have been developed, their effectiveness is limited when facing newly emerging virus strains.

2. **Improvement of neutralizing antibody detection methods**: Traditional neutralizing antibody detection methods such as cytopathic effect (CPE) and fluorescent focus neutralization (FFN) assays, although commonly used, have some limitations. For example, sensitive PRRSV-specific antibodies are difficult to obtain and costly, and these methods are time-consuming.

3. **Development of an efficient and sensitive neutralizing antibody detection platform**: To overcome the aforementioned issues, researchers constructed a recombinant PRRSV (HuN4-F112-eGFP) expressing enhanced green fluorescent protein (eGFP) and developed a novel neutralizing antibody detection method based on this construct. This method can detect the presence of neutralizing antibodies earlier and is more sensitive and faster than traditional methods, aiding in the evaluation of next-generation PRRS vaccines.

In summary, this paper aims to address the challenges in current vaccine development and improve the efficiency and accuracy of neutralizing antibody detection by developing a novel neutralizing antibody detection method based on a recombinant PRRSV expressing eGFP, thereby promoting the development of more effective PRRS control strategies.